Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lttl vs Reset Solutions

Lttl
Graded #204

Higher grade

vs+9.899999999999991
Reset Solutions
Graded #420

Lower grade

The verdict

Lttl takes it — 66.1/100 to 56.2/100.

Lttl grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLttl +11
56
45
Dose & formulationLttl +56
96
40
Clinical oversightReset Solutions +2
76
78
Labs & monitoringReset Solutions +9
52
61
FulfillmentLttl +4
69
65
Contract termsReset Solutions +35
20
55
Lttl · left barReset Solutions · right bar

The numbers

MetricLttlReset Solutions
WeighScore66.1/10056.2/100
GradeCC
Scorecard rank#204#420
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$279/mo (all doses, compounded)Not disclosed
CoverageCoverage not published1 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Lttl

Graded #204 · C

Strengths

  • Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
  • Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
  • States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
  • Oral ODT semaglutide offered for members who want to avoid injections

Where it loses points

  • Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
  • The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
  • No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
  • Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
  • Medications cannot be returned or refunded once they ship from the pharmacy
Reset Solutions

Graded #420 · C

Strengths

  • $99/mo program covers all medical visits, coaching, check-ins, and 3D body-composition testing
  • Medication priced separately starting at $70/month - combined from ~$169/mo, under the compounded-sema market median
  • Full refund if the doctor determines you are not a medical candidate
  • No long-term contract - cancel anytime; lower-cost maintenance plan once established
  • Local care team: in-person kickoff, dose adjustments over time, and app messaging

Where it loses points

  • Texas only - requires an in-person kickoff at its Shenandoah (The Woodlands) clinic
  • Medication form (compounded vs brand) is not stated in page copy; per-drug pricing not itemized
  • Tirzepatide cost not published - only 'starting at $70 per month' across medication options
  • Pharmacy partner not publicly named
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard